✦ LIBER ✦

Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin

✍ Scribed by Bolinder, J.; Ljunggren, Ö.; Johansson, L.; Wilding, J.; Langkilde, A. M.; Sjöström, C. D.; Sugg, J.; Parikh, S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Durability of glycaemic efficacy over 2

✍ Nauck, M. A.; Del Prato, S.; Durán-García, S.; Rohwedder, K.; Langkilde, A. M.; 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 768 KB

Dapagliflozin treatment in patients with

✍ L. Zhang; Y. Feng; J. List; S. Kasichayanula; M. Pfister 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 535 KB

Long-term effects of exenatide therapy o

✍ R. E. Ratner; D. Maggs; L. L. Nielsen; A. H. Stonehouse; T. Poon; B. Zhang; T. A 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

Exenatide elicits sustained glycaemic co

✍ Matthew C. Riddle; Robert R. Henry; Terri H. Poon; Bei Zhang; Susanna M. Mac; Jo 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB

Dapagliflozin has no effect on markers o

✍ Ö. Ljunggren; J. Bolinder; L. Johansson; J. Wilding; A. M. Langkilde; C. D. Sjös 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 883 KB

Lixisenatide treatment improves glycaemi

✍ Yu Pan, Chang ;Han, Ping ;Liu, Xiaoming ;Yan, Shengli ;Feng, Ping ;Zhou, Zhiguan 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 650 KB